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Prion pathogenesis in the absence of Toll-like receptor signalling
Abstract
To reach the brain from peripheral sites, prions must colonize various cell types within the
lymphoreticular compartment. However, no prion entry receptors are yet known. Toll-like receptors
(TLRs) are pattern-recognition receptors that bind a multitude of pathogens and are therefore candidates
as effectors of prion entry. Moreover, injection of unmethylated CpG oligodinucleotides, which
stimulate TLR9, has been reported to delay peripherally initiated scrapie. We therefore studied prion
infection in MyD88(-/-) mice, which are defective in TLR signalling. Despite subtle defects in splenic
microarchitecture, MyD88(-/-) mice challenged intraperitoneally or intracerebrally were fully
susceptible to disease and died of scrapie after similar incubation times to those of wild-type mice.
Splenic infectivity titres rose to similar levels with the same kinetics, and brains showed similar
histopathological changes. TLR signalling therefore does not have any major role in prion pathogenesis,
and the protective effect of TLR stimulation is unlikely to result from direct interactions with prions.
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To reach the brain from peripheral sites, prions must colonize vari-
ous cell types within the lymphoreticular compartment. However,
no prion entry receptors are yet known. Toll-like receptors (TLRs) are
pattern-recognition receptors that bind a multitude of pathogens
and are therefore candidates as effectors of prion entry. Moreover,
injection of unmethylated CpG oligodinucleotides, which stimulate
TLR9, has been reported to delay peripherally initiated scrapie. We
therefore studied prion infection in MyD88−/− mice, which are defec-
tive in TLR signalling. Despite subtle defects in splenic microarchitec-
ture, MyD88−/− mice challenged intraperitoneally or intracerebrally
were fully susceptible to disease and died of scrapie after similar
incubation times to those of wild-type mice. Splenic infectivity titres
rose to similar levels with the same kinetics, and brains showed simi-
lar histopathological changes. TLR signalling therefore does not have
any major role in prion pathogenesis, and the protective effect of TLR
stimulation is unlikely to result from direct interactions with prions.
EMBO reports 4, 195–199 (2003)
doi:10.1038/sj.embor.embor731
INTRODUCTION
Host organisms detect infection by recognizing pathogen-associated
molecular patterns that induce innate responses to infections. Toll-
like receptors (TLRs) are crucial mediators of such responses. Toll is
crucial in antifungal immunity of Drosophila (Lemaitre et al., 1996).
TLRs are mammalian Toll homologues expressed by immune cells.
At least 10 members of the TLR family exist. At present, ligands have
been identified for TLR1 to TLR9. Most of these ligands are derived
from pathogens and comprise a heterogeneous group, including
viruses, bacteria, DNA, RNA, toxins and chemical compounds.
TLR9 is required for immune responses triggered by bacterial DNA
(Hemmi et al., 2000). MyD88 is a cytoplasmic adapter protein that
associates as an obligate functional partner with all members of the
TLR and interleukin-1 receptor (IL-1R) family (Muzio et al., 1997;
Medzhitov et al., 1998). MyD88−/− mice do not show any response
to IL-1 family cytokines in vivo (Adachi et al., 1998), are resistant to
lipopolysaccharide-induced endotoxin shock syndrome (Kawai et
al., 1999), and fail to respond to peptidoglycans and lipoproteins
(Takeuchi et al., 2000), antiviral compounds (Hemmi et al., 2002),
CpG DNA (Hacker et al., 2000) and flagellins (Hayashi et al., 2001).
In prion diseases, the immune system exerts a crucial role during
the early extracerebral phase that follows peripheral administration of
the agent (Aguzzi et al., 2001). B cells (Klein et al., 1997), follicular
dendritic cells (FDCs) (Montrasio et al., 2000) and other haematopoi-
etic and stromal cells in spleen and lymph nodes (Kaeser et al., 2001;
Prinz et al., 2002) are involved in the process of peripheral uptake,
amplification and probably transport of prion infectivity. However,
the receptors used by invading prions to enter host cells are un-
known. FDCs trap opsonized antigens on their surface with Fcγ and
complement receptors, and mice lacking opsonins or complement
receptors are partly protected against the intraperitoneal administra-
tion of prions (Klein et al., 2001; Mabbott et al., 2001). However,
complement is evidently not the only system involved, because com-
plement-deficient mice succumb to scrapie after peripheral chal-
lenge with high doses of scrapie inoculum (Klein et al., 2001).
A recent study has shown that the injection of CpG oligodeoxy-
nucleotides, which stimulate the innate immune system via the TLR9
receptor, provides partial protection against prions administered
intraperitoneally (Sethi et al., 2002). The mechanism underlying this
spectacular finding might be indirect: stimulation of TLR9-expressing
immune cells might trigger a constellation of cytokines and other
mediators that eventually results in an environment unfavourable for
prion replication. Alternatively, prions might conceivably bind and/or
signal through TLRs—a process that could be competed for by ‘thera-
peutic’ TLR ligands. Here we investigated a possible direct role of
TLR-mediated responses in peripheral and central prion pathogenesis
by administering prions peripherally or intracerebrally to mice lack-
ing the cytoplasmic adapter protein MyD88, which is the central
transducer of TLR and IL-1R signalling.
RESULTS
Germinal centres and FDCs in MyD88−/− mice
To judge the extent to which the absence of MyD88 affects the mor-
phology of germinal centres, we examined spleens with immuno-
histochemical stains for B cells, FDCs and complement receptor 1
(Fig. 1). In wild-type littermates from MyD88+/− intercrosses, which
served as control mice, normal shape of the follicles and segregation
of distinct B- and T-cell zones were apparent on spleen sections
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stained with the B cell marker B220. In both MyD88−/− and wild-
type mice the number of germinal centres was similar and ranged
between five and eight in an area of 106 µm2.
However, follicles in MyD88−/− mice seemed to be smaller and
sometimes malformed. Morphometric measurements of more than 50
germinal centres of each genotype stained with B220 revealed that fol-
licles of MyD88−/− mice were significantly smaller than those of wild-
type mice (mean 307 µm versus 493 µm for the full length of trans-
verse sections, P < 0.01). Furthermore, germinal-centre B cells did not
form classical B-cell areas within follicles, and marginal-zone B cells,
a specific subset of B cells that surrounds the germinal centre in a ring-
like fashion, were not visible in the B220 staining in the spleens of
MyD88−/− mice. This finding was demonstrated with immunostains for
complement receptor 1 (CD35), which is expressed in marginal-zone
B cells and in FDCs. Indeed, CD35-positive marginal-zone B cells sur-
rounding the germinal centres were absent from MyD88−/− mice.
FDCs within germinal centres accumulate the disease-associat-
ed prion protein (PrPSc) early during prion diseases. We therefore
stained spleens with monoclonal antibody FDC-M1, a marker of
mature FDCs (Kosco et al., 1992) and of tingible-body
macrophages (Kosco-Vilbois, 2000) (Fig. 1). CD35-positive FDC
networks were also conspicuous in wild-type and MyD88−/− mice.
Morphometric measurements of the FDCs surface-stained with
FDC-M1 showed that similar areas were occupied by this cell type
in MyD88−/− and wild-type mice (2489 ± 1372 µm2 versus 2362 ±
972 µm2; results expressed as mean ± s.d.). However, FDC net-
works in MyD88−/− mice occasionally seemed oddly-shaped and
slightly disorganized when compared with those of wild-type mice
(data not shown).
MyD88−/− mice are highly susceptible to scrapie
Mice deficient for MyD88 were challenged with various quantities
of prions, and the incubation time to terminal disease was mea-
sured. After intracerebral injection with a high dose (3 × 105 LD50) or
a low dose (3 × 102 LD50) of Rocky Mountain Laboratory scrapie
strain (RML), all treated MyD88−/− and wild-type mice reached ter-
minal disease with similar incubation times (Table 1). In both geno-
types, terminal illness was correlated with typical clinical signs of
scrapie such as ataxia, kyphosis, hind leg paresis and, in males, pri-
apism. These results clearly demonstrate that MyD88−/− mice are
highly susceptible to cerebral prion infection.
After high-dose intraperitoneal prion challenge (6 logLD50),
MyD88−/− and wild-type mice developed scrapie with similar incu-
bation times of between 197 and 207 days (Table 1), indicative of
unaffected peripheral prion pathogenesis and neuroinvasion. The
mean incubation time after administration of a 1,000-fold diluted
inoculum (3 logLD50) to MyD88
−/− mice was slightly longer (Table 1).
Five MyD88−/− mice died between 213 and 261 days after injection,
which was superimposable on the incubation range of wild-type
mice. However, two mice had longer incubation times (270 and 274
days after injection), resulting in a larger standard deviation within
this group. A Student’s t-test yielded P > 0.05, indicating that the
incubation times in the two groups were not significantly different.
Importantly, all of these seven peripherally challenged MyD88−/−
mice developed scrapie after administration of a low-dose inocu-
lum, indicating that MyD88 is dispensable for peripheral prion
pathogenesis.
Immunoblot analysis confirmed PrPSc accumulation in the brains
and spleens of terminally ill MyD88−/− mice (Fig. 2). Accordingly,
haematoxylin/eosin stains and glial fibrillary acidic protein (GFAP)
immunohistochemistry of terminally ill mice lacking MyD88 and of
wild-type mice showed similar patterns of vacuolization and of
reactive astrogliosis within the hippocampal ribbon (Fig. 3). Brain
pathology during prion disease was therefore also unaltered in
MyD88−/− mice.
Prion replication in MyD88–/– mice
We then determined prion infectivity over time in spleens of mice
inoculated intraperitoneally (6 logLD50). Infectivity was determined by
transmission of homogenized tissues into tga20 indicator mice
(Fischer et al., 1996) and comparison of incubation times against a cal-
ibration curve. Infectivity in spleens of MyD88−/− (Fig. 4, red circles)
and wild-type (blue circles) mice after intraperitoneal infection was
generally similar in mice of both genotypes. In addition, the time
courses of the process by which prion invaded the spleen were clearly
similar: a considerable amount of infectivity was already present at 35
days after injection in the spleen of both groups. Further measurements
at 90 and 120 days after inoculation confirmed that the levels of prion
infectivity in wild-type and MyD88−/− mice were always very similar. A
lack of MyD88 therefore does not impair the rate and kinetics of lym-
phoreticular prion invasion after intraperitoneal administration.
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Fig. 1 | Morphological appearance of germinal centres in spleens of MyD88−/−
mice. Spleen sections of MyD88-deficient mice (left column) and non-mutant
control littermates (right column) were stained for B cells (B220),
complement receptor 1 (CD35) and FDCs (FDC-M1). Original magnification
of all pictures, ×100.
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DISCUSSION
The innate immune system is the first line of defence against infec-
tion. The most important sensors for the recognition of these invad-
ing microorganisms are the TLRs. Activation of the innate immune
system by CpG oligodeoxynucleotides has been shown to prevent
prion disease in mice (Sethi et al., 2002). This observation is surpris-
ing because activation of the immune system was thought to
enhance, rather than protect from, peripheral prion disease.
Protection might be due to TLR9-mediated immune activation or to
direct competition of PrPSc with TLRs. PrPSc is highly aggregated and
forms ordered molecular arrays (Wille et al., 2002) of congophilic,
anisotropic amyloid with predominant β-sheet conformation. These
characteristics led us to propose that canonical pattern receptors,
such as TLRs, might be involved in prion pathogenesis. However, 
the results presented here imply that prion replication and neuro-
invasion can take place in secondary lymphoreticular organs in the
absence of TLR signalling.
After intraperitoneal low-dose challenge with prions, we ob-
served a delay of 24 days in mean incubation of MyD88−/− in com-
parison with wild-type mice of the same genetic background.
Statistical analysis did not reveal a significant difference between the
two groups. The slight difference might be due to a subtle impair-
ment in germinal-centre architecture of MyD88−/− mice: this com-
partment is of pivotal importance in peripheral prion pathogenesis,
and the observed changes might slightly affect prion pathogenesis.
All other investigated parameters of pathogenesis, such as amount of
PrPSc in infected brains and spleens, kinetics and amount of infectiv-
ity in the spleens, as well as neuropathological changes of end-stage
brains, were identical in MyD88−/− and wild-type mice.
The cytoplasmic portion of TLRs is similar to that of IL-1R and IL-
18R. The signalling pathway via TLRs is therefore homologous to
that of the IL-1R family, and both TLRs and IL-1Rs interact with
MyD88. MyD88−/− mice do not show any response to IL-1 or IL-18
(Adachi et al., 1971). These cytokines might have a significant role
in many neurodegenerative diseases (Allan & Rothwell, 2001).
Expression of IL-1 was detected in brains of animals that were ill
with scrapie (Williams et al., 1994) but another study failed to
reproduce this finding (Walsh et al., 2001). The present study indi-
cates that IL-1R signalling is positively needed neither for peripheral
prion pathogenesis nor for the chronic neurodegeneration seen in
prion disease.
Our findings are not incompatible with the reported prophylactic
effect of CpG oligonucleotides in scrapie-inoculated mice (Sethi 
et al., 2002) but make it unlikely that stimulators of innate immunity
compete with prions for a common pathway. Instead, it is more
likely that strong stimulation of TLRs exerts its effects indirectly, for
example by conjuring an immunological environment generally
hostile to prion infection.
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Fig. 2 | Western blot analysis of brains and spleens of infected MyD88−/−
mice. Western blots of spleen material subjected to electrophoresis in native
form (−) or after digestion with proteinase K (PK) (+) are shown. Similar
amounts of PK-resistant prion protein (PrPSc) were detected in the brains
and spleens of both MyD88−/− and wild-type (WT) mice that had developed
terminal scrapie. PrPSc was detectable in all mice that had been challenged
intraperitoneally (i.p.) or intracerebrally (i.c.) with high (6 logLD
50
or 
3 × 105 LD
50
) or low (3 logLD
50
or 3 × 102 LD
50
) doses of RML. Prnpo/o, mice
deficient for PrPc.
Table 1 | High susceptibility to scrapie of MyD88−/− mice after peripheral and intracerebral prion challenge
Intraperitoneal infection Intracerebral infection
6 logLD50 3 logLD50 3 x 105 LD50 3 x 102 LD50
Mouse Attack Latency Mean ± s.d. Attack Latency Mean ± s.d. Attack Latency Mean ± s.d. Attack Latency Mean ± s.d.
genotype rate (d) (d) rate (d) (d) rate (d) (d) rate (d) (d)
MyD88−/− 6/6 173, 181, 197 ± 17 7/7 215, 225, 249 ± 24 5/5 135, 135, 150 ± 14 4/4 175, 177, 180 ± 6
181, 197, 251, 251, 156, 163, 180, 189
216, 236 261, 270, 163
274
Wild-type 5/5 192, 206, 207 ± 10 5/5 213, 222, 225 ± 10 5/5 135, 135, 145 ± 14 6/6 168, 168, 177 ± 9
MyD88+/+ 206, 213, 222, 225, 135, 156, 177, 186,
220 241 163 186
Prnpo/o n.d. – – 0/5 >370 >370 n.d. – – 0/4 >370 >370
MyD88−/− and wild-type mice developed scrapie after similar incubation periods after administration of a high or a low intracerebral dose of prions. A high peritoneal prion challenge 
(6 logLD
50
) also elicited scrapie with a similar latency, whereas after intraperitoneal challenges with a lower dose (3 logLD
50
) MyD88−/− mice developed terminal disease with a slightly
longer incubation period than wild-type mice. Latency, latency of disease in individual mice. Prnpo/o, mice deficient for PrPc.
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Two caveats still persist before we can conclude that TLRs do 
not have any role in prion diseases. First, activation of TLR4 sig-
nalling was described to occur by an alternative pathway that does
not involve MyD88 (Fitzgerald et al., 2001), and might mediate
some aspects of prion pathogenesis. Second, scrapie prions might
use TLRs for docking to relevant cells but fail to activate MyD88-
mediated signalling. This possibility is not totally remote because
prion infection does not typically elicit strong adaptive immune
reactions.
The identification of the recognition receptors that are involved in
prion entry, replication and accumulation in host cells therefore
continues to be a priority in prion research, because it will help in
our understanding of the molecular pathogenesis of prions and
might even point to prophylactic or therapeutic strategies against
these diseases.
METHODS
Scrapie infections. MyD88+/− mice (Adachi et al., 1998) were interbred
to obtain homozygous and wild-type C57Bl/6 mice. Animals were
maintained under specific pathogen-free conditions and were infected
intraperitoneally with brain homogenate in 100 µl PBS containing 
6 logLD50 or 3 logLD50 units of the RML scrapie strain (passage 5). For
intracerebral inoculations, 30 µl of inoculum with 3 × 105 LD50 or 
3 × 102 LD50 were administered. Mice were monitored every second
day, and scrapie was diagnosed by standard clinical criteria. Mice
were killed on the day of onset of terminal clinical signs of scrapie.
Infectivity bioassay with tga20 indicator mice. Assays were per-
formed on 1% spleen homogenates. Tissues were homogenized in
0.32 M sucrose with a micro-homogenizer, diluted in PBS and 5%
BSA, then passed several times through 18-gauge and 22-gauge nee-
dles. When the solution seemed homogenous, it was centrifuged for
5 min at 500g. Supernatants (30 µl) were inoculated intracerebrally
into groups of four tga20 mice (Fischer et al., 1996). The relationship
y = 11.45 − 0.088x (y, log LD50 per milliliter of homogenate; x, incu-
bation time in days to terminal disease) was calculated by linear
regression (Prusiner et al., 1982; Kaeser et al., 2001).
Western blot analysis. Tissue homogenates were adjusted to 8 mg
ml−1 protein, then treated with proteinase K (20 µg ml−1, 30 min, 37
°C). Total protein (50 µg) was subjected to SDS–12% polyacry-
lamide-gel electrophoresis. Proteins were transferred to nitrocellu-
lose by semi-dry blotting. Membranes were blocked with Tris-
buffered saline containing 0.1% Tween 20, pH 8, plus 5% non-fat
milk, incubated with monoclonal antibody ICSM18 (Hill &
Collinge, 2002) and detected by enhanced chemiluminescence
(ECL; Amersham).
Sick + –
MyD88–/– Wild type
– +
H&E
GFAP
Fig. 3 | Brain pathology of terminally ill mice after intraperitoneal challenge with scrapie. Pronounced astrogliosis (detected with an immunohistochemical stain
for GFAP; lower row) was visible in the hippocampal neuronal ribbon of scrapie-infected (terminal disease) MyD88−/− and wild-type mice, whereas no gliosis and
vacuolization (haematoxylin/eosin stain (H & E); upper row) was found in clinically healthy mice. Original magnification of all micrographs, ×200.
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Fig. 4 | Determination of prion infectivity titres in spleens of infected
MyD88 −/− mice. Titres were determined in spleens of MyD88 −/− mice 
(red circles) and wild-type mice (blue circles). Mice were treated
intraperitoneally with 6 logLD
50
of scrapie prions as indicated.
Standard deviations within groups are drawn only when they exceed 
± 0.50 logLD
50
. a,b In these transmissions 1 out of 4 tga20 mice died 24 h 
after inoculation, most probably as a result of perioperative 
intracerebral bleeding.
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Histology and immunohistochemistry. Paraffin-embedded and frozen
sections from brain and spleen were stained with haematoxylin/eosin.
Immunostaining for the astrocytic marker glial fibrillary acidic protein
(GFAP) was performed with a rabbit antiserum against GFAP (1:300
dilution; DAKO) and detected with biotinylated pig anti-rabbit serum
(1:250 dilution; DAKO) and diaminobenzidine (Sigma). The follicular
dendritic cell marker FDC-M1 (clone 4C11; 1:300 dilution), the com-
plement marker CD35 (8C12; Pharmingen) and the pan-B cell marker
anti-CD45RO/B220 (RA3-6B2; Pharmingen) were used as described
(Karrer et al., 2000). Morphometric analysis was performed with
Analysis Pro 3.1 software (Soft Imaging System).
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